Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS9 | O00182 | 1/20 | 0.55 |
| ▸ | LGALS1 | P09382 | 1/20 | 0.55 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.55 |
| ▸ | LGALS7; LGALS7B | P47929 | 1/20 | 0.55 |
| ▸ | LMNA | P02545 | 2/20 | 0.52 |
| ▸ | F2 | P00734 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 3/20 | 0.48 |
| ▸ | CHRNA7 | P36544 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | HTR3E | A5X5Y0 | 1/20 | 0.44 |
| ▸ | HTR3B | O95264 | 1/20 | 0.44 |
| ▸ | HTR3A | P46098 | 1/20 | 0.44 |
| ▸ | HTR3D | Q70Z44 | 1/20 | 0.44 |
| ▸ | HTR3C | Q8WXA8 | 1/20 | 0.44 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.42 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3856644 | 1.00 | LGALS9 (0.55) | LGALS9LGALS1LGALS3LGALS7; LGALS7BLMNA | |
| SCHEMBL9462783 | 1.00 | LGALS9 (0.55) | LGALS9LGALS1LGALS3LGALS7; LGALS7BLMNA | |
| SCHEMBL3857519 | 1.00 | LGALS9 (0.55) | LGALS9LGALS1LGALS3LGALS7; LGALS7BLMNA | |
| SCHEMBL14215444 | 1.00 | LGALS9 (0.55) | LGALS9LGALS1LGALS3LGALS7; LGALS7BLMNA | |
| SCHEMBL9413961 | 0.98 | LGALS9 (0.54) | LGALS9LGALS1LGALS3LGALS7; LGALS7BLMNA | |
| SCHEMBL4963754 | 0.96 | LMNA (0.52) | LGALS9LGALS1LGALS3LGALS7; LGALS7BLMNA | |
| SCHEMBL12292246 | 0.96 | LMNA (0.52) | LGALS9LGALS1LGALS3LGALS7; LGALS7BLMNA | |
| SCHEMBL12327664 | 0.96 | LMNA (0.52) | LGALS9LGALS1LGALS3LGALS7; LGALS7BLMNA | |
| SCHEMBL4963759 | 0.96 | LMNA (0.52) | LGALS9LGALS1LGALS3LGALS7; LGALS7BLMNA | |
| SCHEMBL9853793 | 0.94 | LGALS9 (0.56) | LGALS9LGALS1LGALS3LGALS7; LGALS7BLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220162422-A1 | METHOD FOR STABILIZING THERMOPLASTIC RECYCLATES, STABILIZED PLASTIC COMPOSITIONS, AND MOLDING COMPOUNDS AND MOLDED PARTS PRODUCED THEREFROM | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e. V. (DE) | 2022-05-26 | — | — | US | disclosed |
| US-9675065-B2 | Biocide and bleach compositions and related methods | TRUOX, INC. (US) | 2017-06-13 | — | — | US | disclosed |
| US-20170105412-A9 | BIOCIDE AND BLEACH COMPOSITIONS AND RELATED METHODS | TRUOX, INC. (US) | 2017-04-20 | — | — | US | disclosed |
| US-20150196027-A1 | BIOCIDE AND BLEACH COMPOSITIONS AND RELATED METHODS | TRUOX, INC. (US) | 2015-07-16 | — | — | US | disclosed |
| WO-2012112278-A1 | BIOCIDE AND BLEACH COMPOSITIONS AND RELATED METHODS | TRUOX, INC. (US) | 2012-08-23 | — | — | WO | disclosed |
| US-20120207858-A1 | BIOCIDE AND BLEACH COMPOSITIONS AND RELATED METHODS | TRUOX, INC. (US) | 2012-08-16 | — | — | US | disclosed |
| US-5026898-A | Cell process controllers | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1991-06-25 | — | — | US | disclosed |
| US-4924023-A | MEDICINE | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1990-05-08 | — | — | US | disclosed |
| US-4873355-A | Process for regioselectively preparing phosphorylated inositols and other cyclitols | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1989-10-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120207858-A1 | BIOCIDE AND BLEACH COMPOSITIONS AND RELATED METHODS | ALKBH2, TET2, CAT | LGALS9 1495/4885LGALS1 1997/4885LGALS3 1788/4885 |
| US-20170105412-A9 | BIOCIDE AND BLEACH COMPOSITIONS AND RELATED METHODS | ALKBH2, TET2, CAT | LGALS9 1495/4885LGALS1 1997/4885LGALS3 1788/4885 |
| US-20150196027-A1 | BIOCIDE AND BLEACH COMPOSITIONS AND RELATED METHODS | ALKBH2, TET2, CAT | LGALS9 1495/4885LGALS1 1997/4885LGALS3 1788/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.